ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,929Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 1211

$631K Total Retail Price of All Prescriptions

Rank: 58 out of 1211

644 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 10,087 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
METOPROLOL SUCCINATE 1,090 983 1 5
INDAPAMIDE 688 633 10 2 118
CRESTOR 622 566 3 11
LISINOPRIL 581 536 4 6
SIMVASTATIN 412 371 5 1
POTASSIUM CHLORIDE 343 318 6 19
METOPROLOL TARTRATE 305 286 7 4
ATORVASTATIN CALCIUM 303 272 8 9
CARVEDILOL 295 266 9 3
LOSARTAN POTASSIUM 269 264 10 12
AMLODIPINE BESYLATE 267 251 11 2
CITALOPRAM HBR 232 205 12 67
DIOVAN 232 226 12 21
BISOPROLOL FUMARATE 217 217 14 51
CLOPIDOGREL 214 174 15 10
ATENOLOL 204 201 16 13
FOSINOPRIL SODIUM 200 194 17 143
PLAVIX 180 160 18 14
NITROSTAT 160 125 19 26
BUMETANIDE 138 137 20 71
FENOFIBRATE 133 122 21 42
LEVOTHYROXINE SODIUM 126 113 22 22
DOXAZOSIN MESYLATE 120 120 23 48
BENICAR 119 119 24 69
LOVAZA 118 108 25 52
RANEXA 113 111 26 40
BISOPROLOL-HYDROCHLOROTHIAZIDE 110 110 27 122
METFORMIN HCL 105 98 28 27
LOSARTAN-HYDROCHLOROTHIAZIDE 105 99 28 29
HYDRALAZINE HCL 99 95 30 47
PRADAXA 98 98 31 23
OMEPRAZOLE 91 83 32 20
TEKTURNA 74 74 33 162
MELOXICAM 73 60 34 88
RAMIPRIL 68 58 35 25
LIPITOR 67 59 36 38
DIOVAN HCT 60 48 37 35
ISOSORBIDE MONONITRATE ER 60 56 37 16
BENICAR HCT 60 57 37 78
ADVAIR DISKUS 56 55 40 84
NIFEDIPINE ER 55 55 41 43
NITROLINGUAL 55 38 41 339
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 51 43 39
BENAZEPRIL HCL 52 52 44 85
CLONIDINE HCL 52 52 44 34
ESCITALOPRAM OXALATE 50 46 46 89
DIAZEPAM 50 49 46 286
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.